Anupama Srinivasan is a prominent inventor based in Redwood City, California. She has made significant contributions to the field of prenatal diagnostics, holding a total of eight patents. Her work focuses on non-invasive methods for determining fetal genetic conditions, which have the potential to revolutionize prenatal care.

Latest Patents

One of Anupama's latest patents involves non-invasive prenatal diagnosis of fetal genetic conditions using cellular DNA and cell-free DNA. This patent discloses methods for determining at least one sequence of interest of a fetus from a pregnant mother. The method can analyze a test sample that comprises a mixture of maternal cellular DNA and mother-and-fetus cfDNA. In various embodiments, the methods can determine whether the fetus has a genetic disease, whether the fetus is homozygous in a disease-causing allele when the mother is heterozygous, and whether the fetus has a copy number variation (CNV) or a non-CNV genetic sequence anomaly.

Career Highlights

Anupama has worked with notable companies in the biotechnology sector, including Verinata Health, Inc. and Illumina Corporation. Her experience in these organizations has allowed her to develop and refine her innovative approaches to prenatal diagnostics.

Collaborations

Anupama has collaborated with esteemed colleagues such as Richard P. Rava and Darya Chudova. These partnerships have contributed to her success and the advancement of her research in the field.

Conclusion

Anupama Srinivasan is a trailblazer in the realm of non-invasive prenatal diagnostics, with a strong portfolio of patents that reflect her innovative spirit. Her work continues to impact the field positively, paving the way for advancements in prenatal care.

This text is generated by artificial intelligence and may not be accurate.